Activation of blood coagulation in cancer: Trousseau's syndrome revisited

Blood. 1983 Jul;62(1):14-31.
No abstract available

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Antibodies / immunology
  • Aspirin / therapeutic use
  • Blood Coagulation Disorders / complications
  • Blood Coagulation Factors / biosynthesis
  • Blood Platelets / immunology
  • Cell Adhesion
  • Cell Communication
  • Cyclooxygenase Inhibitors
  • Disseminated Intravascular Coagulation / complications
  • Epoprostenol / therapeutic use
  • Fibrin Fibrinogen Degradation Products / analysis
  • Fibrinogen / biosynthesis
  • Fibrinopeptide A / analysis
  • Humans
  • Indomethacin / therapeutic use
  • Monocytes / physiology
  • Neoplasm Transplantation
  • Neoplasms / complications*
  • Neoplasms / drug therapy
  • Syndrome
  • Thrombocytopenia / complications
  • Thrombocytosis / complications
  • Thromboembolism / complications*
  • Thromboplastin / physiology

Substances

  • Antibodies
  • Blood Coagulation Factors
  • Cyclooxygenase Inhibitors
  • Fibrin Fibrinogen Degradation Products
  • Fibrinopeptide A
  • Fibrinogen
  • Thromboplastin
  • Epoprostenol
  • Aspirin
  • Indomethacin